Home

Thomas DiRaimondo, Chief Scientific Officer: Janux Therapeutics JANX Sell · Filed 01/02

Trade details

Type
Insider sale
Amount
$34,393.65
Shares · price
2,505 sh · $13.73 a share
Held after
124,425 sh
Trade date
26/01/02
Filed
26/01/02
Days to filing
0 days

Sold 2.0% of holdings

Share of holding sold
2.0%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

Thomas DiRaimondo's recent trades

  • Thomas DiRaimondo

    Sell10b5-1 planJanux Therapeutics

    $199.9K

    Filed 24/09/27

  • Thomas DiRaimondo

    Sell10b5-1 planJanux Therapeutics

    $31.9K

    Filed 24/09/27